Large Cap Archives - Page 43 of 437

2 minute read

US Home Prices Rocket In February For Strongest One-Month Increase In 2 Years: Real Estate Stocks React

April 30, 12:36 PM

Home prices defied high mortgage costs and surpassed expectations with a 1.2% month-over-month growth, the largest increase since Apr 2022.

BRX

2 minute read

What’s Going On With Marathon Petroleum Shares Today?

By Lekha Gupta

April 30, 11:59 AM

Marathon Petroleum shares down after reporting Q1 FY24 results. Revenue at $33.211B, adjusted EPS at $2.78, operating costs increase.

FTXN

2 minute read

Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab

By Vandana Singh

April 30, 11:54 AM

Sandoz resolves patent litigation with Amgen, paving the way for the launch of denosumab biosimilars Jubbonti and Wyost.

AMGN

2 minute read

GE HealthCare’s Q1 Earnings Miss Wall Street Projections, But It Sticks To Annual Guidance

By Vandana Singh

April 30, 11:31 AM

GE Healthcare reports first-quarter sales of $4.6 billion, with net income of $374 million. Imaging and ultrasound segment revenues down, but pharmaceutical diagnostics up. Despite challenges in China, CEO remains optimistic, reaffirming guidance for 2024.

GEHC

2 minute read

Why Is Hospital Chain Operator Tenet Healthcare Stock Soaring On Tuesday?

By Vandana Singh

April 30, 10:53 AM

Discover Tenet Healthcare's robust first-quarter performance, boasting $5.37 billion in sales, a 7% Y/Y increase. With strong revenue growth, admissions, and profitability, Tenet is raising its fiscal year 2024 revenue guidance to $20-$20.4 billion.

THC

2 minute read

Eaton Boosts 2024 Guidance As Electrical And Aerospace Sectors Excel

By Lekha Gupta

April 30, 10:47 AM

Eaton reports strong Q1 FY24 results with record sales of $5.94B, 8% Y/Y growth, and increased backlog. Q2 outlook exceeds expectations and FY24 guidance raised.

ETN

2 minute read

Eli Lilly’s Weight-Loss Drug Still Going Strong, Boosts Annual Forecast

By Vandana Singh

April 30, 9:41 AM

"Eli Lilly & Co's Q1 2024: Revenue hits $8.8 billion, up 26% Y/Y, driven by volume & higher prices. Strong demand for key drugs like Mounjaro & Verzenio. EPS beats at $2.58. FY24 guidance raised to $42.4 billion-$43.6 billion, citing robust performance.

LLY

2 minute read

Goldman Sachs Tempers Investor Excitement On Tesla Self-Driving Tech In China: ‘Not Yet An Eyes-Off, Unsupervised Product’

By Piero Cingari

April 30, 9:01 AM

Goldman Sachs is keeping excitement over Tesla's partnership with Baidu in check. FSD faces regulatory hurdles in China, one analyst notes.

BIDU

1 minute read

What’s Going On With Logitech Shares Premarket Tuesday?

By Lekha Gupta

April 30, 8:47 AM

Logitech reported better than expected fourth-quarter results. Revenue up 5%, adjusted gross margin at 43.6%. FY25 outlook positive.

LOGI

1 minute read

Nigeria Reportedly Audits Shell’s $1.3B Onshore Oilfield Sale

By Lekha Gupta

April 30, 6:19 AM

The Nigerian oil regulator evaluates Shell's divestment of its onshore subsidiary to Renaissance consortium. Assets have 6.73B barrels of oil & 56.27T cubic feet of gas.

HAP